Published in PLoS One on September 04, 2012
Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity. Chem Biol (2015) 1.53
Oligonucleotide aptamers: new tools for targeted cancer therapy. Mol Ther Nucleic Acids (2014) 1.49
New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization. Mol Ther Nucleic Acids (2014) 1.21
FASTAptamer: A Bioinformatic Toolkit for High-throughput Sequence Analysis of Combinatorial Selections. Mol Ther Nucleic Acids (2015) 1.11
Large scale analysis of the mutational landscape in HT-SELEX improves aptamer discovery. Nucleic Acids Res (2015) 1.11
Current progress on aptamer-targeted oligonucleotide therapeutics. Ther Deliv (2013) 1.09
Multifunctional aptamer-miRNA conjugates for targeted cancer therapy. Mol Ther (2014) 1.03
Development of an efficient targeted cell-SELEX procedure for DNA aptamer reagents. PLoS One (2013) 0.95
MPBind: a Meta-motif-based statistical framework and pipeline to Predict Binding potential of SELEX-derived aptamers. Bioinformatics (2014) 0.95
Aptamers and their applications in nanomedicine. Small (2015) 0.88
Aptamer Selection Technology and Recent Advances. Mol Ther Nucleic Acids (2016) 0.88
RAPID-SELEX for RNA aptamers. PLoS One (2013) 0.88
Cell-internalization SELEX: method for identifying cell-internalizing RNA aptamers for delivering siRNAs to target cells. Methods Mol Biol (2015) 0.87
Methods for Evaluating Cell-Specific, Cell-Internalizing RNA Aptamers. Pharmaceuticals (Basel) (2013) 0.86
From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors. PLoS One (2014) 0.86
Identification of RNA aptamers that internalize into HPV-16 E6/E7 transformed tonsillar epithelial cells. Virology (2013) 0.86
Selection of DNA aptamers for ovarian cancer biomarker HE4 using CE-SELEX and high-throughput sequencing. Anal Bioanal Chem (2015) 0.85
Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment. Nucleic Acids Res (2015) 0.85
Potent Inhibition of HIV-1 Reverse Transcriptase and Replication by Nonpseudoknot, "UCAA-motif" RNA Aptamers. Mol Ther Nucleic Acids (2013) 0.84
Analyzing HT-SELEX data with the Galaxy Project tools - A web based bioinformatics platform for biomedical research. Methods (2015) 0.81
Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells. Oncotarget (2015) 0.80
Fitness Landscapes of Functional RNAs. Life (Basel) (2015) 0.79
High throughput sequencing analysis of RNA libraries reveals the influences of initial library and PCR methods on SELEX efficiency. Sci Rep (2016) 0.79
Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer. Pharmaceuticals (Basel) (2016) 0.79
Efficient HIV-1 inhibition by a 16 nt-long RNA aptamer designed by combining in vitro selection and in silico optimisation strategies. Sci Rep (2014) 0.78
Targeting Insulin Receptor with a Novel Internalizing Aptamer. Mol Ther Nucleic Acids (2016) 0.78
Blocking interaction of viral gp120 and CD4-expressing T cells by single-stranded DNA aptamers. Int J Biochem Cell Biol (2014) 0.77
In Vivo Selection Against Human Colorectal Cancer Xenografts Identifies an Aptamer That Targets RNA Helicase Protein DHX9. Mol Ther Nucleic Acids (2016) 0.77
Development of Phosphorothioate DNA and DNA Thioaptamers. Biomedicines (2017) 0.76
AptaTRACE Elucidates RNA Sequence-Structure Motifs from Selection Trends in HT-SELEX Experiments. Cell Syst (2016) 0.76
Aptaligner: automated software for aligning pseudorandom DNA X-aptamers from next-generation sequencing data. Biochemistry (2014) 0.76
Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects. Biomedicines (2017) 0.76
Selection of DNA Aptamers for Ovarian Cancer Biomarker CA125 Using One-Pot SELEX and High-Throughput Sequencing. J Nucleic Acids (2017) 0.75
In vitro RNA SELEX for the generation of chemically-optimized therapeutic RNA drugs. Methods (2016) 0.75
Galaxy Workflows for Web-based Bioinformatics Analysis of Aptamer High-throughput Sequencing Data. Mol Ther Nucleic Acids (2016) 0.75
Smooth Muscle Cell-targeted RNA Aptamer Inhibits Neointimal Formation. Mol Ther (2016) 0.75
Cell-SELEX Identifies a "Sticky" RNA Aptamer Sequence. J Nucleic Acids (2017) 0.75
AFBI assay - Aptamer Fluorescence Binding and Internalization assay for cultured adherent cells. Methods (2016) 0.75
Manipulating the in vivo immune response by targeted gene knockdown. Curr Opin Immunol (2015) 0.75
Aptamer Cell-Based Selection: Overview and Advances. Biomedicines (2017) 0.75
Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res (1981) 61.59
Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science (1990) 35.96
In vitro selection of RNA molecules that bind specific ligands. Nature (1990) 30.19
The equilibrium partition function and base pair binding probabilities for RNA secondary structure. Biopolymers (1990) 10.92
ViennaRNA Package 2.0. Algorithms Mol Biol (2011) 9.43
Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature (1992) 7.61
Aptamers as therapeutics. Nat Rev Drug Discov (2010) 5.36
Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res (2002) 4.16
A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci U S A (2003) 3.28
Retracted Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol (2005) 2.77
RNA aptamers as reversible antagonists of coagulation factor IXa. Nature (2002) 2.73
A mutant T7 RNA polymerase as a DNA polymerase. EMBO J (1995) 2.63
Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial regulatory protein pigpen. J Biol Chem (2001) 2.53
High affinity ligands from in vitro selection: complex targets. Proc Natl Acad Sci U S A (1998) 2.30
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice. J Clin Invest (2008) 2.18
Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing. Proc Natl Acad Sci U S A (2010) 2.01
Variations on RNA folding and alignment: lessons from Benasque. J Math Biol (2007) 1.91
Inhibitory DNA ligands to platelet-derived growth factor B-chain. Biochemistry (1996) 1.91
Identification of liver cancer-specific aptamers using whole live cells. Anal Chem (2008) 1.90
Tenascin-C aptamers are generated using tumor cells and purified protein. J Biol Chem (2001) 1.81
Selection and characterization of an RNA decoy for transcription factor NF-kappa B. Biochemistry (1999) 1.77
Complex target SELEX. Acc Chem Res (2008) 1.71
Molecular recognition of acute myeloid leukemia using aptamers. Leukemia (2009) 1.63
Therapeutic applications of DNA and RNA aptamers. Oligonucleotides (2009) 1.59
Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3. Proc Natl Acad Sci U S A (2003) 1.54
Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers. Nucleic Acids Res (2012) 1.47
RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells. Mol Ther (2008) 1.38
Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2'F-RNA aptamers. J Virol (2003) 1.37
In vivo selection of tumor-targeting RNA motifs. Nat Chem Biol (2009) 1.36
Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res (1999) 1.35
Probing the SELEX process with next-generation sequencing. PLoS One (2011) 1.34
Mechanism of ribose 2'-group discrimination by an RNA polymerase. Biochemistry (1997) 1.32
High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. Proc Natl Acad Sci U S A (1993) 1.29
Monitoring genomic sequences during SELEX using high-throughput sequencing: neutral SELEX. PLoS One (2010) 1.28
Targeting cancer cells with nucleic acid aptamers. Trends Biotechnol (2010) 1.26
Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2. Curr Cancer Drug Targets (2008) 1.24
Simultaneous generation of aptamers to multiple gamma-carboxyglutamic acid proteins from a focused aptamer library using DeSELEX and convergent selection. Oligonucleotides (2007) 1.20
Controlling small guanine-nucleotide-exchange factor function through cytoplasmic RNA intramers. Proc Natl Acad Sci U S A (2001) 1.20
Isolation and optimization of murine IL-10 receptor blocking oligonucleotide aptamers using high-throughput sequencing. Mol Ther (2012) 1.19
Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis. Biochem Biophys Res Commun (2007) 1.18
CELL-SELEX: Novel perspectives of aptamer-based therapeutics. Int J Mol Sci (2008) 1.17
Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling. Nucleic Acid Ther (2011) 1.16
Nucleotide bias observed with a short SELEX RNA aptamer library. Nucleic Acid Ther (2011) 1.15
Probing the limits of aptamer affinity with a microfluidic SELEX platform. PLoS One (2011) 1.14
Differential SELEX in human glioma cell lines. PLoS One (2009) 1.13
Cutting edge: novel RNA ligands able to bind CD4 antigen and inhibit CD4+ T lymphocyte function. J Immunol (1998) 1.11
Optimizing aptamer activity for gene therapy applications using expression cassette SELEX. Mol Ther (2002) 1.06
Isolation of high-affinity RNA ligands to HIV-1 integrase from a random pool. Virology (1995) 1.06
Cell-specific aptamers as emerging therapeutics. J Nucleic Acids (2011) 1.04
Selection of DNA ligands for protein kinase C-delta. Chem Commun (Camb) (2006) 1.04
Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease. Eur J Biochem (2000) 1.03
Discriminatory aptamer reveals serum response element transcription regulated by cytohesin-2. Proc Natl Acad Sci U S A (2004) 1.02
Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia. Proc Natl Acad Sci U S A (2007) 1.01
Targeted inhibition of alphavbeta3 integrin with an RNA aptamer impairs endothelial cell growth and survival. Biochem Biophys Res Commun (2005) 1.00
Label-free aptamer-based colorimetric detection of mercury ions in aqueous media using unmodified gold nanoparticles as colorimetric probe. Anal Bioanal Chem (2009) 0.96
Selection and design of high-affinity RNA ligands for HIV-1 Rev. Gene (1993) 0.95
A calibrated diversity assay for nucleic acid libraries using DiStRO--a Diversity Standard of Random Oligonucleotides. Nucleic Acids Res (2009) 0.94
Isolation and characterization of 2'-fluoro-, 2'-amino-, and 2'-fluoro-/amino-modified RNA ligands to human IFN-gamma that inhibit receptor binding. J Immunol (1997) 0.92
Degradation of nuclease-stabilized RNA oligonucleotides in Mycoplasma-contaminated cell culture media. Nucleic Acid Ther (2012) 0.92
Highly potent irreversible inhibitors of neutrophil elastase generated by selection from a randomized DNA-valine phosphonate library. Biochemistry (1997) 0.86
RNA ligands to human nerve growth factor. Nucleic Acids Res (1995) 0.86
Targeting inhibition of GluR1 Ser845 phosphorylation with an RNA aptamer that blocks AMPA receptor trafficking. J Neurochem (2008) 0.83
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol (2006) 6.30
Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat Biotechnol (2004) 5.40
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat Biotechnol (2009) 3.78
A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol (2006) 3.46
Effects of sodium ions on DNA duplex oligomers: improved predictions of melting temperatures. Biochemistry (2004) 3.00
Functional polarity is introduced by Dicer processing of short substrate RNAs. Nucleic Acids Res (2005) 2.83
E2Fs link the control of G1/S and G2/M transcription. EMBO J (2004) 2.81
Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2005) 2.42
Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res (2011) 2.39
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice. J Clin Invest (2008) 2.18
Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress. Cell Metab (2011) 2.16
Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy. Circulation (2008) 1.95
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol (2014) 1.95
Hybridization kinetics and thermodynamics of molecular beacons. Nucleic Acids Res (2003) 1.88
miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors. EMBO J (2011) 1.75
Rational design and in vitro and in vivo delivery of Dicer substrate siRNA. Nat Protoc (2006) 1.74
Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay. Nature (2010) 1.73
Analysis of nontypeable haemophilus influenzae phase-variable genes during experimental human nasopharyngeal colonization. J Infect Dis (2013) 1.64
Predicting stability of DNA duplexes in solutions containing magnesium and monovalent cations. Biochemistry (2008) 1.63
Progress toward in vivo use of siRNAs-II. Mol Ther (2011) 1.60
Therapeutic applications of DNA and RNA aptamers. Oligonucleotides (2009) 1.59
Design of LNA probes that improve mismatch discrimination. Nucleic Acids Res (2006) 1.59
Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Physiol Genomics (2006) 1.57
Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology (2005) 1.54
Structure-function relationships of shared-stem and conventional molecular beacons. Nucleic Acids Res (2002) 1.51
Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers. Nucleic Acids Res (2012) 1.47
Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model. Mol Ther (2008) 1.47
Effects of fluorescent dyes, quenchers, and dangling ends on DNA duplex stability. Biochem Biophys Res Commun (2005) 1.44
Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitro. Nat Biotechnol (2006) 1.44
A miR-19 regulon that controls NF-κB signaling. Nucleic Acids Res (2012) 1.43
IDT SciTools: a suite for analysis and design of nucleic acid oligomers. Nucleic Acids Res (2008) 1.37
Serum levels of leptin, insulin, and lipids in relation to breast cancer in china. Endocrine (2005) 1.37
A potential role for RNA interference in controlling the activity of the human LINE-1 retrotransposon. Nucleic Acids Res (2005) 1.34
Gene silencing by synthetic U1 adaptors. Nat Biotechnol (2009) 1.29
Hybridization of 2'-O-methyl and 2'-deoxy molecular beacons to RNA and DNA targets. Nucleic Acids Res (2002) 1.26
A role for the Dicer helicase domain in the processing of thermodynamically unstable hairpin RNAs. Nucleic Acids Res (2008) 1.25
Advances in molecular and cellular therapies for hearing loss. Mol Ther (2007) 1.25
TLR7 is involved in sequence-specific sensing of single-stranded RNAs in human macrophages. J Immunol (2008) 1.25
Spectroscopic features of dual fluorescence/luminescence resonance energy-transfer molecular beacons. Anal Chem (2003) 1.24
A direct comparison of anti-microRNA oligonucleotide potency. Pharm Res (2010) 1.22
Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs. Oligonucleotides (2008) 1.17
Population genetics of duplicated disease-defense genes, hm1 and hm2, in maize (Zea mays ssp. mays L.) and its wild ancestor (Zea mays ssp. parviglumis). Genetics (2002) 1.16
Efficient cytosolic delivery of molecular beacon conjugates and flow cytometric analysis of target RNA. Nucleic Acids Res (2008) 1.16
Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling. Nucleic Acid Ther (2011) 1.16
Nucleotide bias observed with a short SELEX RNA aptamer library. Nucleic Acid Ther (2011) 1.15
RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin. Mol Ther (2007) 1.14
The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. Free Radic Biol Med (2002) 1.14
Alternative RISC assembly: binding and repression of microRNA-mRNA duplexes by human Ago proteins. RNA (2012) 1.13
Avoiding false-positive signals with nuclease-vulnerable molecular beacons in single living cells. Nucleic Acids Res (2007) 1.12
Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins. Arterioscler Thromb Vasc Biol (2003) 1.11
A role for human Dicer in pre-RISC loading of siRNAs. Nucleic Acids Res (2010) 1.11
Cell-specific aptamers for targeted therapies. Methods Mol Biol (2009) 1.11
Role for Nox1 NADPH oxidase in atherosclerosis. Atherosclerosis (2011) 1.11
An oxidized extracellular oxidation-reduction state increases Nox1 expression and proliferation in vascular smooth muscle cells via epidermal growth factor receptor activation. Arterioscler Thromb Vasc Biol (2010) 1.10
Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression. Arterioscler Thromb Vasc Biol (2006) 1.10
Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide Modifier. Mol Ther Nucleic Acids (2013) 1.10
Design of active small interfering RNAs. Curr Opin Mol Ther (2007) 1.10
Current progress on aptamer-targeted oligonucleotide therapeutics. Ther Deliv (2013) 1.09
Characterization of modified antisense oligonucleotides in Xenopus laevis embryos. Oligonucleotides (2006) 1.08
A microRNA network regulates expression and biosynthesis of wild-type and DeltaF508 mutant cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A (2012) 1.07
Right- and left-loop short shRNAs have distinct and unusual mechanisms of gene silencing. Nucleic Acids Res (2012) 1.07
β-Adrenergic receptor antagonists ameliorate myocyte T-tubule remodeling following myocardial infarction. FASEB J (2012) 1.06
Intracellular delivery of RNA-based therapeutics using aptamers. Ther Deliv (2010) 1.05
Gp91phox contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells. Am J Physiol Heart Circ Physiol (2003) 1.05
Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration. Cardiovasc Res (2011) 1.05
Activation of swelling-activated chloride current by tumor necrosis factor-alpha requires ClC-3-dependent endosomal reactive oxygen production. J Biol Chem (2010) 1.03
Determinants of cytokine induction by small interfering RNA in human peripheral blood mononuclear cells. J Interferon Cytokine Res (2008) 1.03
Temporal control of cell cycle gene expression mediated by E2F transcription factors. Cell Cycle (2005) 1.03
High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1. J Virol (2013) 1.02
Electrophysiology of reactive oxygen production in signaling endosomes. Antioxid Redox Signal (2009) 1.02
Early gestation dexamethasone programs enhanced postnatal ovine coronary artery vascular reactivity. Am J Physiol Regul Integr Comp Physiol (2004) 1.02
Effects of chemical modification on the potency, serum stability, and immunostimulatory properties of short shRNAs. RNA (2009) 1.02
Rational design of immunostimulatory siRNAs. Mol Ther (2010) 1.02
Synthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA. Int J Pharm (2011) 1.01
Hybridization of 2'-O-methyl and 2'-deoxy molecular beacons to RNA and DNA targets. Nucleic Acids Res (2003) 1.00
Targeted inhibition of alphavbeta3 integrin with an RNA aptamer impairs endothelial cell growth and survival. Biochem Biophys Res Commun (2005) 1.00
Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells. J Immunol (2004) 1.00
Intraperitoneal administration of chitosan/DsiRNA nanoparticles targeting TNFα prevents radiation-induced fibrosis. Radiother Oncol (2010) 0.99
Central delivery of Dicer-substrate siRNA: a direct application for pain research. Mol Ther (2008) 0.99
Erlotinib-mediated inhibition of EGFR signaling induces metabolic oxidative stress through NOX4. Cancer Res (2011) 0.99
Reactive oxygen species mediate arachidonic acid-induced dilation in porcine coronary microvessels. Am J Physiol Heart Circ Physiol (2003) 0.98
In vivo SELEX for Identification of Brain-penetrating Aptamers. Mol Ther Nucleic Acids (2013) 0.98
Synthesis and radiolabeling of chelator-RNA aptamer bioconjugates with copper-64 for targeted molecular imaging. Bioorg Med Chem (2011) 0.98
Pancreas-enriched miRNA refines endocrine cell differentiation. Development (2012) 0.97
NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitor erlotinib in head and neck cancer cells. Toxicol Appl Pharmacol (2013) 0.97
Marsupial-specific microRNAs evolved from marsupial-specific transposable elements. Gene (2009) 0.96
Assessing the sensitivity of commercially available fluorophores to the intracellular environment. Anal Chem (2008) 0.96
Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 0.95
Generation of an oligonucleotide array for analysis of gene expression in Chlamydomonas reinhardtii. Curr Genet (2005) 0.95
Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis. Circulation (2013) 0.95
Ratiometric bimolecular beacons for the sensitive detection of RNA in single living cells. Nucleic Acids Res (2010) 0.95
Regression of atherosclerosis in monkeys reduces vascular superoxide levels. Circ Res (2002) 0.95
Opportunity nox: the future of NADPH oxidases as therapeutic targets in cardiovascular disease. Cardiovasc Ther (2012) 0.94
A human claudin-1-derived peptide inhibits hepatitis C virus entry. Hepatology (2012) 0.94
Coordinated DNA methylation and gene expression changes in smoker alveolar macrophages: specific effects on VEGF receptor 1 expression. J Leukoc Biol (2012) 0.93